NCT04746131 2022-09-26Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Phase 1 Suspended90 enrolled
NCT03704714 2022-08-15Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell LymphomaNorthwestern UniversityPhase 1/2 Suspended30 enrolled
NCT04697290 2022-02-14CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.Beijing Tsinghua Chang Gung HospitalPhase EARLY_PHASE1 Suspended12 enrolled